Adrenocorticotropic hormone (ACTH) is an alternative treatment for patients who cannot tolerate or do not respond to these treatments (Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group, 2021). Here, POMC is linked to kidney disorder.